Literature DB >> 20949333

Time intervals and myocardial performance index by tissue Doppler imaging.

Michele Correale1, Antonio Totaro, Riccardo Ieva, Natale Daniele Brunetti, Matteo Di Biase.   

Abstract

The application of tissue Doppler imaging (TDI) has shown remarkable growth in clinical practice during the past few years, especially, in risk stratification of patients with coronary heart disease or heart failure (systolic and diastolic). Myocardial performance index (MPI) is a Doppler echocardiographic parameter defined as the sum of the isovolemic contraction and relaxation times divided by the ejection time. It is considered as a reliable parameter to assess global left ventricular function. Cardiac time intervals and MPI have also been found as new applications in diagnosing cardiotoxicity from chemotherapy, COPD, valvular heart disease, pulmonary hypertension and endocrinopathies.

Entities:  

Mesh:

Year:  2010        PMID: 20949333     DOI: 10.1007/s11739-010-0469-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  40 in total

1.  Disagreement between tissue Doppler imaging and conventional pulsed wave Doppler in the measurement of myocardial performance index.

Authors:  Eduardo Casas Rojo; José Luis Rodrigo; Leopoldo Pérez de Isla; Carlos Almería; Nieves Gonzalo; Adalía Aubele; Rafael Cinza; José Zamorano; Carlos Macaya
Journal:  Eur J Echocardiogr       Date:  2005-09-29

2.  Effects of cardiac resynchronization therapy on the Doppler Tei index.

Authors:  Toshinori Yuasa; Chinami Miyazaki; Jae K Oh; Raul E Espinosa; Charles J Bruce
Journal:  J Am Soc Echocardiogr       Date:  2009-01-29       Impact factor: 5.251

3.  Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

Authors:  C Tei; R A Nishimura; J B Seward; A J Tajik
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

4.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

5.  Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure.

Authors:  Tayfun Acil; Thomas Wichter; Jörg Stypmann; Frauke Janssen; Matthias Paul; Matthias Grude; Hans H Scheld; Günter Breithardt; Christian Bruch
Journal:  Int J Cardiol       Date:  2005-01-08       Impact factor: 4.164

6.  Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique.

Authors:  C Jarnert; M Mejhert; M Ring; H Persson; M Edner
Journal:  Eur J Heart Fail       Date:  2000-06       Impact factor: 15.534

7.  Reproducibility of pulsed wave tissue Doppler echocardiography.

Authors:  D Vinereanu; A Khokhar; A G Fraser
Journal:  J Am Soc Echocardiogr       Date:  1999-06       Impact factor: 5.251

8.  Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parameters.

Authors:  Osama I I Soliman; Dominic A M J Theuns; Folkert J Ten Cate; Attila Nemes; Kadir Caliskan; Aggie H M M Balk; Wim B Vletter; Luc J Jordaens; Marcel L Geleijnse
Journal:  J Card Fail       Date:  2007-12       Impact factor: 5.712

9.  Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index.

Authors:  Merih Baykan; Cihangir Erem; Omer Gedikli; Arif Hacihasanoğlu; Turan Erdoğan; Mustafa Koçak; Sahin Kaplan; Abdülkadir Kiriş; Sükrü Celik
Journal:  Echocardiography       Date:  2008-01-03       Impact factor: 1.724

10.  Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's Syndrome.

Authors:  Merih Baykan; Cihangir Erem; Omer Gedikli; Arif Hacihasanoglu; Turan Erdogan; Mustafa Kocak; Sahin Kaplan; Abdulkadir Kiriş; Cihan Orem; Sükrü Celik
Journal:  Echocardiography       Date:  2008-02       Impact factor: 1.724

View more
  7 in total

1.  Assessment of ventricular functions by tissue Doppler echocardiography in children with asthma.

Authors:  Osman Ozdemir; Yasemin Ceylan; Cem Hasan Razi; Ozben Ceylan; Nesibe Andiran
Journal:  Pediatr Cardiol       Date:  2012-09-11       Impact factor: 1.655

2.  Tissue Doppler Imaging and Focal, Late-Onset Anthracycline-Induced Cardiovascular Disease in Long Term Survivors of Childhood Cancer: A Research Article.

Authors:  Prakadeshwari Rajapreyar; Adonis Lorenzana; Anuradha Prabhu; Susan Szpunar; Premchand Anne
Journal:  J Clin Diagn Res       Date:  2016-08-01

3.  Evaluation of the left and right ventricular systolic and diastolic function in asthmatic children.

Authors:  Esra Akyüz Özkan; Hashem E Khosroshahi
Journal:  BMC Cardiovasc Disord       Date:  2016-07-08       Impact factor: 2.298

Review 4.  Tissue Doppler imaging in coronary artery diseases and heart failure.

Authors:  Michele Correale; Antonio Totaro; Riccardo Ieva; Armando Ferraretti; Francesco Musaico; Matteo Di Biase
Journal:  Curr Cardiol Rev       Date:  2012-02

5.  Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry.

Authors:  M Correale; A Totaro; T Passero; S Abruzzese; F Musaico; A Ferraretti; R Ieva; M Di Biase; N D Brunetti
Journal:  Neth Heart J       Date:  2013-09       Impact factor: 2.380

6.  Assessment of cardiac functions in infants with cow's milk allergy.

Authors:  Ibrahim Ece; Kaan Demirören; Nihat Demir; Abdurrahman Uner; Sevket Balli
Journal:  Med Sci Monit       Date:  2014-08-06

7.  Impact of effect-site concentration of propofol on cardiac systolic function assessed by tissue Doppler imaging.

Authors:  Chung-Sik Oh; Yungu Lee; Woon-Seok Kang; Seong-Hyop Kim
Journal:  J Int Med Res       Date:  2016-04-05       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.